| Application no. and date | 00969283.1 (espacenet) (Federated) (European Patent Register), 20000922 | | Patent/reg. no. and date | DK/EP 1223927, 20050209 | | Publication date | 20020724 | | Priority no. and date | US 406135, 19990927 | | EP pub. no. and date |
EP 1223927 20020724 | | Effective date | | | Applicant/owner | Valeant Pharmaceuticals North America, 3300 Hyland Avenue
Costa Mesa
CA 92626, US | | Applicant ref. no. | 122009 | | Inventor | BARTSCH, Reni, Weinbergstrasse 23
01458 Ottendorf-Okrilla, DE,
ROSTOCK, Angelika, Makarenko Strasse 7
01445 Radebeul, DE,
TOBER, Christine, Reichsstrasse 24
01689 Weinböhla, DE,
RUNDFELDT, Chris, Melanchthonstrasse 11
01640 Coswig, DE,
DOST, Rita, Südhöhe 51
01217 Dresden, DE | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/325 (2006.01) , A61P 29/02 (2006.01) | | Title | Anvendelse af retigabin til behandling af neuropatiske smerter | | Int. application no. | EP2000009284 | | Int. publication no. | WO2001022953 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
